Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Helicobacter pylori infection in functional dyspepsia

Nature Reviews Gastroenterology & Hepatology volume 10, pages 168–174 (2013)Cite this article

Subjects

Abstract

Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.

Key Points

  • Helicobacter pylori infection is a major cause of gastritis and is associated with a variety of motility, endocrine and acid-secretory abnormalities that could drive the symptoms of functional dyspepsia

  • In a meta-analysis of randomized controlled trials, H. pylori eradication had a small but statistically significant effect in controlling the symptoms of functional dyspepsia

  • H. pylori eradication improves symptoms in patients with epigastric-pain-predominant and postprandial-distress-predominant functional dyspepsia

  • The majority of guidelines recommend H. pylori eradication in at least a subset of patients with functional dyspepsia

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Symptoms of chronic gastritis caused by Helicobacter pylori infection.

Similar content being viewed by others

References

  1. Talley, N. J., Phillips, S. F., Melton, J. 3rd, Wiltgen, C. & Zinsmeister, A. R. A patient questionnaire to identify bowel disease. Ann. Intern. Med. 111, 671–674 (1989).

    Article  CAS  PubMed  Google Scholar 

  2. Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. & Moayyedi, P. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am. J. Gastroenterol. 107, 912–921 (2012).

    Article  PubMed  Google Scholar 

  3. Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. & Moayyedi, P. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 56, 321–327 (2007).

    Article  PubMed  Google Scholar 

  4. Ford, A. C., Marwaha, A., Lim, A. & Moayyedi, P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 8, 830–837 e831–e832 (2010).

    Article  PubMed  Google Scholar 

  5. Moayyedi, P. Dyspepsia. Curr. Opin. Gastroenterol. 28, 602–607 (2012).

    Article  PubMed  Google Scholar 

  6. Porter, C. K., Gormley, R., Tribble, D. R., Cash, B. D. & Riddle, M. S. The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am. J. Gastroenterol. 106, 130–138 (2011).

    Article  PubMed  Google Scholar 

  7. Liebregts, T. et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am. J. Gastroenterol. 106, 1089–1098 (2011).

    Article  CAS  PubMed  Google Scholar 

  8. Ford, A. C. et al. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology 138, 1727–1736 (2010).

    Article  PubMed  Google Scholar 

  9. Bazzoli, F. et al. The Loiano–Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors. Aliment. Pharmacol. Ther. 15, 1001–1007 (2001).

    Article  CAS  PubMed  Google Scholar 

  10. Suzuki, M. et al. H. pylori-eradication therapy increases RUNX3 expression in the glandular epithelial cells in enlarged-fold gastritis. J. Clin. Biochem. Nutr. 46, 259–264 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Suzuki, H., Nishizawa, T. & Hibi, T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J. Gastroenterol. 41, 513–523 (2006).

    Article  PubMed  Google Scholar 

  12. Suzuki, H., Hibi, T. & Marshall, B. J. Helicobacter pylori: present status and future prospects in Japan. J. Gastroenterol. 42, 1–15 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Suzuki, H., Nishizawa, T., Tsugawa, H., Mogami, S. & Hibi, T. Roles of oxidative stress in stomach disorders. J. Clin. Biochem. Nutr. 50, 35–39 (2012).

    Article  CAS  PubMed  Google Scholar 

  14. Suzuki, H., Suzuki, M., Imaeda, H. & Hibi, T. Helicobacter pylori and microcirculation. Microcirculation 16, 547–558 (2009).

    Article  PubMed  Google Scholar 

  15. Suzuki, S. et al. Delayed gastric emptying and disruption of the interstitial cells of Cajal network after gastric ischaemia and reperfusion. Neurogastroenterol. Motil. 22, 585–593 (2010).

    Article  CAS  PubMed  Google Scholar 

  16. Mogami, S. et al. Reduced ghrelin production induced anorexia after rat gastric ischemia and reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G359–G364 (2012).

    Article  CAS  PubMed  Google Scholar 

  17. Savarino, E., Zentilin, P., Dulbecco, P., Malesci, A. & Savarino, V. The role of acid in functional dyspepsia. Am. J. Gastroenterol. 106, 1168 (2011).

    Article  PubMed  Google Scholar 

  18. El-Omar, E., Penman, I., Dorrian, C. A., Ardill, J. E. & McColl, K. E. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34, 1060–1065 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Amieva, M. R. & El-Omar, E. M. Host–bacterial interactions in Helicobacter pylori infection. Gastroenterology 134, 306–323 (2008).

    Article  CAS  PubMed  Google Scholar 

  20. Hurlimann, S. et al. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Am. J. Gastroenterol. 93, 1277–1285 (1998).

    Article  CAS  PubMed  Google Scholar 

  21. McColl, K. E., El-Omar, E. & Gillen, D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br. Med. Bull. 54, 121–138 (1998).

    Article  CAS  PubMed  Google Scholar 

  22. Koike, T. et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49, 330–334 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Moss, S. F., Legon, S., Bishop, A. E., Polak, J. M. & Calam, J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340, 930–932 (1992).

    Article  CAS  PubMed  Google Scholar 

  24. Odum, L., Petersen, H. D., Andersen, I. B., Hansen, B. F. & Rehfeld, J. F. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35, 615–618 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kamada, T. et al. The association between antral G and D cells and mucosal inflammation, atrophy, and Helicobacter pylori infection in subjects with normal mucosa, chronic gastritis, and duodenal ulcer. Am. J. Gastroenterol. 93, 748–752 (1998).

    Article  CAS  PubMed  Google Scholar 

  26. Calam, J., Gibbons, A., Healey, Z. V., Bliss, P. & Arebi, N. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 113, S43–S49 (1997).

    Article  CAS  PubMed  Google Scholar 

  27. Mulholland, G. et al. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 34, 757–761 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Liu, Y., Vosmaer, G. D., Tytgat, G. N., Xiao, S. D. & Ten Kate, F. J. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. J. Clin. Pathol. 58, 927–931 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Konturek, J. W., Bielanski, W., Konturek, S. J. & Domschke, W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J. Physiol. Pharmacol. 47, 161–175 (1996).

    CAS  PubMed  Google Scholar 

  30. Suzuki, H. et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 53, 187–194 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Osawa, H. et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J. Clin. Endocrinol. Metab. 90, 10–16 (2005).

    Article  CAS  PubMed  Google Scholar 

  32. Suzuki, H. et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 51, 1249–1254 (2004).

    CAS  PubMed  Google Scholar 

  33. Isomoto, H. et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am. J. Gastroenterol. 100, 1711–1720 (2005).

    Article  CAS  PubMed  Google Scholar 

  34. Dong, C. X. & Brubaker, P. L. Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nat. Rev. Gastroenterol. Hepatol. 9, 705–715 (2012).

    Article  CAS  PubMed  Google Scholar 

  35. Mori, M. et al. Intravenous ghrelin administration enhances gastric acid secretion—evaluation using wireless pH capsule. Aliment. Pharmacol. Ther. 24, 96–103 (2006).

    Article  Google Scholar 

  36. Arai, M. et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 59, 62–66 (2012).

    PubMed  Google Scholar 

  37. Iijima, K. et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 46, 20–26 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Osawa, H. et al. Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa. Gut 55, 152–157 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Osawa, H. et al. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J. Gastroenterol. 41, 954–961 (2006).

    Article  CAS  PubMed  Google Scholar 

  40. Masaoka, T. et al. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication. Hepatogastroenterology 52, 1–4 (2005).

    PubMed  Google Scholar 

  41. Tatsuguchi, A. et al. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am. J. Gastroenterol. 99, 2121–2127 (2004).

    Article  CAS  PubMed  Google Scholar 

  42. Jang, E. J. et al. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J. Gastroenterol. Hepatol. 23 (Suppl. 2), S278–S285 (2008).

    Article  CAS  PubMed  Google Scholar 

  43. Choe, Y. H. et al. Ghrelin levels in gastric mucosa before and after eradication of Helicobacter pylori. Gut Liver 1, 132–137 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Nogueiras, R., Williams, L. M. & Dieguez, C. Ghrelin: new molecular pathways modulating appetite and adiposity. Obes. Facts 3, 285–292 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Miyaji, H. et al. The effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 13, 1473–1480 (1999).

    Article  CAS  PubMed  Google Scholar 

  46. Matsumoto, Y. et al. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography. J. Gastroenterol. 43, 332–337 (2008).

    Article  PubMed  Google Scholar 

  47. Kachi, M. et al. Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the 13C-octanoic acid breath test and the acetaminophen method. J. Gastroenterol. Hepatol. 21, 824–830 (2006).

    Article  PubMed  Google Scholar 

  48. Saito, Y. et al. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology 140, 189–198 (2011).

    Article  CAS  PubMed  Google Scholar 

  49. Tack, J. et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther. 22, 847–853 (2005).

    Article  CAS  PubMed  Google Scholar 

  50. Murray, C. D. et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54, 1693–1698 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. US National Library of Medicine. ClinicalTrials.gov [online], (2012).

  52. Hall, W., Buckley, M., Crotty, P. & O'Morain, C. A. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin. Gastroenterol. Hepatol. 1, 363–369 (2003).

    Article  PubMed  Google Scholar 

  53. Miyamoto, M. et al. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig. Dis. Sci. 48, 968–975 (2003).

    Article  PubMed  Google Scholar 

  54. Dwivedi, M., Misra, S. P. & Misra, V. Nodular gastritis in adults: clinical features, endoscopic appearance, histopathological features, and response to therapy. J. Gastroenterol. Hepatol. 23, 943–947 (2008).

    Article  PubMed  Google Scholar 

  55. Murayama, Y. et al. Morphological and functional restoration of parietal cells in Helicobacter pylori associated enlarged fold gastritis after eradication. Gut 45, 653–661 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Matsunari, O. et al. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J. Clin. Microbiol. 50, 876–883 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Suzuki, H., Nishizawa, T. & Hibi, T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J. Gastroenterol. Hepatol. 26 (Suppl. 3), 42–45 (2011).

    Article  PubMed  Google Scholar 

  58. Suzuki, H., Matsuzaki, J. & Hibi, T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J. Neurogastroenterol. Motil. 17, 124–130 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  59. Sugano, K. Should we still subcategorize Helicobacter pylori-associated dyspepsia as functional disease? J. Neurogastroenterol. Motil. 17, 366–371 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  60. Yagi, K., Aruga, Y., Nakamura, A. & Sekine, A. Regular arrangement of collecting venules (RAC): a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J. Gastroenterol. 40, 443–452 (2005).

    Article  PubMed  Google Scholar 

  61. Anagnostopoulos, G. K. et al. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy 39, 202–207 (2007).

    Article  CAS  PubMed  Google Scholar 

  62. Suzuki, H. et al. Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease. Keio J. Med. 52, 163–173 (2003).

    Article  PubMed  Google Scholar 

  63. McColl, K. et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N. Engl. J. Med. 339, 1869–1874 (1998).

    Article  CAS  PubMed  Google Scholar 

  64. Blum, A. L. et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin effect one year after treatment (OCAY) Study Group. N. Engl. J. Med. 339, 1875–1881 (1998).

    Article  CAS  PubMed  Google Scholar 

  65. Laine, L., Schoenfeld, P. & Fennerty, M. B. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann. Intern. Med. 134, 361–369 (2001).

    Article  CAS  PubMed  Google Scholar 

  66. Moayyedi, P. et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 321, 659–664 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Moayyedi, P., Deeks, J., Talley, N. J., Delaney, B. & Forman, D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am. J. Gastroenterol. 98, 2621–2626 (2003).

    Article  PubMed  Google Scholar 

  68. Mazzoleni, L. E. et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch. Intern. Med. 171, 1929–1936 (2011).

    Article  PubMed  Google Scholar 

  69. Moayyedi, P. Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on “Helicobacter pylori eradication in functional dyspepsia”. Arch. Intern. Med. 171, 1936–1937 (2011).

    Article  PubMed  Google Scholar 

  70. Moayyedi, P. et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002096. doi:10.1002/14651858.CD002096.pub5 (2006).

  71. Jin, X. & Li, Y. M. Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter 12, 541–546 (2007).

    Article  PubMed  Google Scholar 

  72. Moayyedi, P., Delaney, B. C., Vakil, N., Forman, D. & Talley, N. J. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 127, 1329–1337 (2004).

    Article  PubMed  Google Scholar 

  73. Moayyedi, P. et al. Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 17, 1215–1227 (2003).

    Article  CAS  PubMed  Google Scholar 

  74. Abraham, N. S., Moayyedi, P., Daniels, B. & Veldhuyzen Van Zanten, S. J. Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment. Pharmacol. Ther. 19, 631–641 (2004).

    Article  CAS  PubMed  Google Scholar 

  75. Kindt, S. et al. Longitudinal and cross-sectional factors associated with long-term clinical course in functional dyspepsia: a 5-year follow-up study. Am. J. Gastroenterol. 106, 340–348 (2011).

    Article  PubMed  Google Scholar 

  76. Moayyedi, P. & Leontiadis, G. I. The risks of PPI therapy. Nat. Rev. Gastroenterol. Hepatol. 9, 132–139 (2012).

    Article  CAS  PubMed  Google Scholar 

  77. Basu, P. P. et al. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am. J. Gastroenterol. 106, 1970–1975 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Watson, J. B. & Moss, S. F. Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. Am. J. Gastroenterol. 106, 1976–1977 (2011).

    Article  CAS  PubMed  Google Scholar 

  79. Geeraerts, B. & Tack, J. Functional dyspepsia: past, present, and future. J. Gastroenterol. 43, 251–255 (2008).

    Article  PubMed  Google Scholar 

  80. Tack, J., Masaoka, T. & Janssen, P. Functional dyspepsia. Curr. Opin. Gastroenterol. 27, 549–557 (2011).

    Article  CAS  PubMed  Google Scholar 

  81. Talley, N. J., Janssens, J., Lauritsen, K., Racz, I. & Bolling-Sternevald, E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 318, 833–837 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Hsu, P. I. et al. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment. Pharmacol. Ther. 15, 195–201 (2001).

    Article  CAS  PubMed  Google Scholar 

  83. Gwee, K. A. et al. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 21, 417–424 (2009).

    Article  PubMed  Google Scholar 

  84. Bruley Des Varannes, S. et al. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 15, 1177–1185 (2001).

    Article  CAS  PubMed  Google Scholar 

  85. Lan, L. et al. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J. Gastroenterol. 17, 3242–3247 (2011).

    PubMed  PubMed Central  Google Scholar 

  86. Lee, K. J., Vos, R., Janssens, J. & Tack, J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G278–G284 (2004).

    Article  CAS  PubMed  Google Scholar 

  87. Ang, D. et al. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterol. Motil. 21, 528–533 (2009).

    Article  CAS  PubMed  Google Scholar 

  88. Lacy, B. E. et al. Review article: current treatment options and management of functional dyspepsia. Aliment. Pharmacol. Ther. 36, 3–15 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Bytzer, P. et al. Diagnosis and treatment of Helicobacter pylori infection. Dan. Med. Bull. 58, C4271 (2011).

    PubMed  Google Scholar 

  90. Jee, S. R. et al. Guidelines for the treatment of functional dyspepsia [Korean]. Korean J. Gastroenterol. 57, 67–81 (2011).

    Article  PubMed  Google Scholar 

  91. Fischbach, W. Short version of the S3 (level 3) guideline “Helicobacter pylori and gastroduodenal ulcer disease” from the German Society for Digestive and Metabolic Diseases [German]. Dtsch. Med. Wochenschr. 134, 1830–1834 (2009).

    Article  CAS  PubMed  Google Scholar 

  92. Chey, W. D. & Wong, B. C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 102, 1808–1825 (2007).

    Article  CAS  PubMed  Google Scholar 

  93. Fock, K. M. et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 24, 1587–1600 (2009).

    Article  PubMed  Google Scholar 

  94. Miwa, H. et al. Asian consensus report on functional dyspepsia. J. Gastroenterol. Hepatol. 27, 626–641 (2012).

    Article  PubMed  Google Scholar 

  95. Asaka, M. et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15, 1–20 (2010).

    Article  CAS  PubMed  Google Scholar 

  96. Malfertheiner, P. et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report. Gut 61, 646–664 (2012).

    Article  CAS  PubMed  Google Scholar 

  97. Ford, A. C., Delaney, B. C., Forman, D. & Moayyedi, P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am. J. Gastroenterol. 99, 1833–1855 (2004).

    Article  PubMed  Google Scholar 

  98. Sanchez-Delgado, J. et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am. J. Gastroenterol. 106, 398–405 (2011).

    Article  PubMed  Google Scholar 

  99. Gonzalez, C. A. et al. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am. J. Gastroenterol. 106, 867–874 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Health and Labour Sciences Research Grant for Research on Health Technology Assessment (Clinical Research Promotion No. 47 to H. Suzuki) and a grant from the Smoking Research Foundation (to H. Suzuki), and the Keio Gijuku Academic Development Fund (to H. Suzuki).

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Hidekazu Suzuki

  2. Division of Gastroenterology, Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, 1280 Main Street West, Hamilton, L8S 4K1, ON, Canada

    Paul Moayyedi

Authors
  1. Hidekazu Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Moayyedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors contributed to all aspects of this article.

Corresponding author

Correspondence to Hidekazu Suzuki.

Ethics declarations

Competing interests

H. Suzuki has accepted research grants and honoraria from Astellas, AstraZeneca, Eisai, Otsuka, Daiichi–Sankyo, Dainippon–Sumitomo, Takeda, Tsumura and Zeria over the past 5 years. P. Moayyedi has accepted honoraria from AstraZeneca, Abbott, Pendopharm, Shire and Takeda over the past 5 years. His endowed Chair is partially funded by an unrestricted donation to McMaster University from AstraZeneca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, H., Moayyedi, P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 10, 168–174 (2013). https://doi.org/10.1038/nrgastro.2013.9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2013.9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing